Artificial Intelligence-Enabled Stool Analysis for Lactulose Titration Assistance in Hepatic Encephalopathy Through a Smartphone Application

被引:4
作者
Sordi Chara, Beatriz [1 ]
Hara, Kamalpreet S. [1 ]
Penrice, Daniel [1 ]
Schmidt, Kathryn A. [1 ]
Kassmeyer, Blake A. [1 ]
Anstey, Jacob [2 ]
Tiede, David [2 ]
Kamath, Patrick S. [1 ]
Shah, Vijay H. [1 ]
Bajaj, Jasmohan S. [3 ,4 ]
Kraus, Asaf [2 ]
Simonetto, Douglas A. [1 ]
机构
[1] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA
[2] Dieta Hlth, Oak Pk, CA USA
[3] Virginia Commonwealth Univ, Richmond, VA USA
[4] Richmond VA Med Ctr, Richmond, VA USA
关键词
Bristol Stool Scale; chronic liver disease; cirrhosis; decompensated cirrhosis; lactulose;
D O I
10.14309/ajg.0000000000002656
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
INTRODUCTION: Management of hepatic encephalopathy relies on self-titration of lactulose. In this feasibility trial, we assess an artificial intelligence-enabled tool to guide lactulose use through a smartphone application. METHODS: Subjects with hepatic encephalopathy on lactulose captured bowel movement pictures during lead-in and intervention phases. During the intervention phase, daily feedback on lactulose titration was delivered through the application. Goals were determined according to number of bowel movement and Bristol Stool Scale reports. RESULTS: Subjects completed the study with more than 80% satisfaction. In the lead-in phase, less compliant subjects achieved Bristol Stool Scale goal on 62/111 (56%) of days compared with 107/136 (79%) in the intervention phase (P = 0.041), while the most compliant subjects showed no difference. Severe/recurrent hepatic encephalopathy group achieved Bristol Stool Scale goal on 80/104 (77%) days in the lead-in phase and 90/110 (82%) days in the intervention phase (P = NS), compared with 89/143 (62%) days and 86/127 (68%) days in the stable group. DISCUSSION: Dieta application is a promising tool for objective Bowel Movement/Bristol Stool Scale tracking for hepatic encephalopathy and may potentially be used to assist with lactulose titration.
引用
收藏
页码:982 / 986
页数:5
相关论文
共 10 条
[1]   Predictors of the recurrence of hepatic encephalopathy in lactulose-treated patients [J].
Bajaj, J. S. ;
Sanyal, A. J. ;
Bell, D. ;
Gilles, H. ;
Heuman, D. M. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 31 (09) :1012-1017
[2]  
Chen Mei, 2020, Healthc Manage Forum, V33, P10, DOI 10.1177/0840470419873123
[3]   Global burden of liver disease: 2023 update [J].
Devarbhavi, Harshad ;
Asrani, Sumeet K. ;
Arab, Juan Pablo ;
Nartey, Yvonne Ayerki ;
Pose, Elisa ;
Kamath, Patrick S. .
JOURNAL OF HEPATOLOGY, 2023, 79 (02) :516-537
[4]   Bristol Stool Scale as a Determinant of Hepatic Encephalopathy Management in Patients With Cirrhosis [J].
Duong, Nikki K. ;
Shrestha, Shreesh ;
Park, Dan ;
Shahab, Omer ;
Fagan, Andrew ;
Malpaya, Zenaida ;
Gallagher, Mary L. ;
Morris, April ;
Davis, Brian C. ;
Bajaj, Jasmohan S. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (02) :295-300
[5]   Liver cirrhosis [J].
Gines, Pere ;
Krag, Aleksander ;
Abraldes, Juan G. ;
Sola, Elsa ;
Fabrellas, Nuria ;
Kamath, Patrick S. .
LANCET, 2021, 398 (10308) :1359-1376
[6]   Long-term management of hepatic encephalopathy with lactulose and/or rifaximin: a review of the evidence [J].
Hudson, Mark ;
Schuchmann, Marcus .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 31 (04) :434-450
[7]   Covert and Overt Hepatic Encephalopathy: Diagnosis and Management [J].
Patidar, Kavish R. ;
Bajaj, Jasmohan S. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (12) :2048-2061
[8]   A Smartphone Application Using Artificial Intelligence Is Superior To Subject Self-Reporting When Assessing Stool Form [J].
Pimentel, Mark ;
Mathur, Ruchi ;
Wang, Jiajing ;
Chang, Christine ;
Hosseini, Ava ;
Fiorentino, Alyson ;
Rashid, Mohamad ;
Pichetshote, Nipaporn ;
Basseri, Benjamin ;
Treyzon, Leo ;
Chang, Bianca ;
Leite, Gabriela ;
Morales, Walter ;
Weitsman, Stacy ;
Kraus, Asaf ;
Rezaie, Ali .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (07) :1118-1124
[9]   Burden of Cirrhosis on Patients and Caregivers [J].
Volk, Michael L. .
HEPATOLOGY COMMUNICATIONS, 2020, 4 (08) :1107-1111
[10]   Hepatic Encephalopathy [J].
Wijdicks, Eelco F. M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (17) :1660-1670